share_log

BRIEF-Cybin Acquires Dmt Clinical Study From Entheon Biomedical

reuters ·  Jun 7, 2022 21:05

June 7 (Reuters) - Cybin Inc CYBN.NLB :

* CYBIN ACQUIRES DMT CLINICAL STUDY FROM ENTHEON BIOMEDICAL

* CYBIN INC- PURCHASE PRICE OF ACQUISITION IS $1,000,000 (CAD)

Source text for Eikon: ID:nBw20D4Bma Further company coverage: CYBN.NLB

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment